You just read:

Indivior Announces Health Canada Approval of SUBLOCADE™ (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder

News provided by

Indivior PLC

Nov 23, 2018, 09:56 ET